Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Explore ways to earn money on the side. Find effective strategies that can help you increase your income without a full-time commitment.
13,964 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Microsoft’s stock has fallen out of step with broader AI enthusiasm as Copilot results lag and cloud growth cools, le...
Starting with real estate can feel overwhelming. This guide breaks down the best types rental properties for beginner...
A major shakeup in AI deals spotlights coding as a premier use case for generative AI. Google hires Windsurf talent a...
As summer kicks off, the 2027 cola calculation officially begins its data-driven cycle. Learn what to watch, how it a...
A hot new memory ETF has surged, but can it keep climbing? This analysis breaks down what powers the rally, the risks...
SpaceX's SPCX debut fueled by momentum faces GE Aerospace's steady earnings machine. Investors grapple with spcx inve...
Google and Apple are leading the AI stock surge. This piece weighs valuation, growth, and cash flow to answer which m...
Insider moves can mislead, but context matters. This article explains why Nick Khan’s 9,589 share sale isn’t a warnin...
Chevron is expanding its footprint beyond traditional oil and gas as it eyes large-scale power deals. A landmark 2.7 ...
A fresh platform named For Traders is attracting attention as early reviews praise security and tools but flag costs ...